Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ursodeoxycholic Acid”

156 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 156 results

Not applicableActive Not RecruitingNCT06278090
What this trial is testing

Impact of Ursodeoxycholic Acid Treatment on the Gallbladder Polyp Evolution

Who this might be right for
Gallbladder Polyp
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 36
Large-scale testing (Phase 3)Active Not RecruitingNCT06383403
What this trial is testing

Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

Who this might be right for
Primary Biliary Cholangitis
Ipsen 69
Testing effectiveness (Phase 2)UnknownNCT01688375
What this trial is testing

The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice

Who this might be right for
Obstructive Jaundice
University Clinical Centre of Kosova 54
Post-approval studies (Phase 4)Study completedNCT01510860
What this trial is testing

Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary Cirrhosis
Dr. Falk Pharma GmbH 65
Large-scale testing (Phase 3)UnknownNCT02916641
What this trial is testing

Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid

Who this might be right for
Primary Biliary Cirrhosis
Xijing Hospital of Digestive Diseases 200
Not applicableUnknownNCT02319629
What this trial is testing

Preventive Therapy With Ursodiol to Reduce the Incidence of Gallstones Formation in Patients After Bariatric Surgery

Who this might be right for
Morbid Obesity
HaEmek Medical Center, Israel 266
Post-approval studies (Phase 4)Study completedNCT01974336
What this trial is testing

The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients

Who this might be right for
Short Bowel Syndrome
Jinling Hospital, China 30
Not applicableStudy completedNCT05685888
What this trial is testing

Effect of Ursodeoxycholic Acid on Preventing Covid-19 Infection in Patients With Organ Transplantation

Who this might be right for
Organ TransplantationCOVID-19
First Affiliated Hospital Xi'an Jiaotong University 2,000
Testing effectiveness (Phase 2)Study completedNCT03840005
What this trial is testing

Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The "UP" Study

Who this might be right for
Parkinson's Disease
Sheffield Teaching Hospitals NHS Foundation Trust 31
Testing effectiveness (Phase 2)Study completedNCT01899703
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus

Who this might be right for
Cholestasis, Intrahepatic
GlaxoSmithKline 22
Testing effectiveness (Phase 2)WithdrawnNCT02420496
What this trial is testing

Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants

Who this might be right for
CholestasisLiver Disease
The University of Texas Health Science Center at San Antonio
Testing effectiveness (Phase 2)Study completedNCT04834557
What this trial is testing

Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Tanta University 90
Testing effectiveness (Phase 2)WithdrawnNCT02965911
What this trial is testing

Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA

Who this might be right for
Primary Biliary Cirrhosis
Beijing 302 Hospital
Post-approval studies (Phase 4)UnknownNCT04618575
What this trial is testing

Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1

Who this might be right for
HepatitisPrimary Biliary CholangitisAutoimmune
West China Hospital 137
Testing effectiveness (Phase 2)Study completedNCT05973370
What this trial is testing

Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Tanta University 60
Post-approval studies (Phase 4)Looking for participantsNCT04650243
What this trial is testing

Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

Who this might be right for
Primary Biliary Cholangitis
Peking Union Medical College Hospital 90
Testing effectiveness (Phase 2)Study completedNCT03226067
What this trial is testing

Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.

Who this might be right for
Primary Biliary Cirrhosis
Calliditas Therapeutics AB 111
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Large-scale testing (Phase 3)Study completedNCT00808743
What this trial is testing

Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis

Who this might be right for
Familial Adenomatous PolyposisDuodenal NeoplasmsDuodenal Polyps
Radboud University Medical Center 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06842472
What this trial is testing

PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Load More Results